Proton radiotherapy for high-risk pediatric neuroblastoma: Early outcomes and dose comparison

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 3, 2012, Pages 1015-1022

  Hattangadi, Jona A ^a   Rombi, Barbara ^b,c   Yock, Torunn I ^b   Broussard, George ^b   Friedmann, Alison M ^b   Huang, Mary ^b   Chen, Yen Lin E ^b   Lu, Hsiao Ming ^b   Kooy, Hanne ^b   MacDonald, Shannon M ^b  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c Provincial Agency for Proton Therapy   (Italy)

Author keywords

High risk neuroblastoma; IMPT; IMRT; Intensity modulated proton radiotherapy; Intensity modulated radiotherapy; Proton radiotherapy

Indexed keywords

IMPT; IMRT; INTENSITY-MODULATED RADIOTHERAPY; NEUROBLASTOMAS; PROTON RADIOTHERAPY;

CHEMOTHERAPY; DIAGNOSIS; PHYSICAL THERAPY; PROTON BEAMS; PROTONS; RADIOTHERAPY; STEM CELLS; TUMORS;

THREE DIMENSIONAL;

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MYC PROTEIN; VINCRISTINE;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CHILD; CHROMOSOME 1P; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CLINICAL EXAMINATION; DISEASE CONTROL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INDUCTION CHEMOTHERAPY; INFANT; INTENSITY MODULATED RADIATION THERAPY; LABORATORY TEST; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; MINIMAL RESIDUAL DISEASE; NEUROBLASTOMA; PRESCHOOL CHILD; PRIMARY TUMOR; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; TREATMENT OUTCOME; TUMOR VOLUME; WHOLE BODY RADIATION;

CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INDUCTION CHEMOTHERAPY; INFANT; MALE; NEOPLASM, RESIDUAL; NEUROBLASTOMA; ORGAN SPARING TREATMENTS; ORGANS AT RISK; PHOTONS; PROTONS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84861610870     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.08.035     Document Type: Article

References (20)

1. L.C. Bowman, M.L. Hancock, and V.M. Santana Impact of intensified therapy on clinical outcome in infants and children with neuroblastoma: The St. Jude Children's Research Hospital experience, 1962 to 1988 J Clin Oncol 9 1991 1599 1608
2. R.E. George, S. Li, and C. Medeiros-Nancarrow High-risk neuroblastoma treated with tandem autologous peripheral-blood stem cell-supported transplantation: Long-term survival update J Clin Oncol 24 2006 2891 2896
3. D.A. Haas-Kogan, P.S. Swift, and M. Selch Impact of radiotherapy for high-risk neuroblastoma: A Children's Cancer Group study Int J Radiat Oncol Biol Phys 56 2003 28 39
4. B.H. Kushner, S. Wolden, and M.P. LaQuaglia Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery J Clin Oncol 19 2001 2821 2828
5. S.M. Bradfield, J.G. Douglas, and D.S. Hawkins Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma Cancer 100 2004 1268 1275
6. A.M. Gillis, E. Sutton, and K.D. Dewitt Long-term outcome and toxicities of intraoperative radiotherapy for high-risk neuroblastoma Int J Radiat Oncol Biol Phys 69 2007 858 864
7. H.G. Gatcombe, R.B. Marcus Jr., and H.M. Katzenstein Excellent local control from radiation therapy for high-risk neuroblastoma Int J Radiat Oncol Biol Phys 74 2009 1549 1554
8. J.R. Robbins, M.J. Krasin, and A.S. Pai Panandiker Radiation therapy as part of local control of metastatic neuroblastoma: The St. Jude Children's Research Hospital experience J Pediatr Surg 45 2010 678 686
9. T.E. Merchant Proton beam therapy in pediatric oncology Cancer J 15 2009 298 305
10. A.J. Lomax, T. Boehringer, and A. Coray Intensity modulated proton therapy: A clinical example Med Phys 28 2001 317 324
11. National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE), version 4.0 Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4. 03-2010-06-14-QuickReference-5x7.pdf Accessed February 16, 2011
12. A.S. Pai Panandiker, L. McGregor, and M.J. Krasin Locoregional tumor progression after radiation therapy influences overall survival in pediatric patients with neuroblastoma Int J Radiat Oncol Biol Phys 76 2010 1161 1165
13. A.C. Paulino, N.A. Mayr, and J.H. Simon Locoregional control in infants with neuroblastoma: Role of radiation therapy and late toxicity Int J Radiat Oncol Biol Phys 52 2002 1025 1031
14. Children's Oncology Group Protocol ANBL0532: A phase III randomized trial of single versus tandem myeloablative consolidation therapy for high-risk neuroblastoma Available from: https://members.childrensoncologygroup.org/Prot/ ANBL0532/ANBL0532DOC.pdf Accessed March 3, 2011
15. C. Rubino, E. Adjadj, and S. Guerin Long-term risk of second malignant neoplasms after neuroblastoma in childhood: Role of treatment Int J Cancer 107 2003 791 796
16. E.J. Sutton, R.T. Tong, and A.M. Gillis Decreased aortic growth and middle aortic syndrome in patients with neuroblastoma after radiation therapy Pediatr Radiol 39 2009 1194 1202
17. A.C. Paulino, M.S. Ferenci, and K.Y. Chiang Comparison of conventional to intensity modulated radiation therapy for abdominal neuroblastoma Pediatr Blood Cancer 46 2006 739 744
18. M. Hillbrand, D. Georg, and H. Gadner Abdominal cancer during early childhood: A dosimetric comparison of proton beams to standard and advanced photon radiotherapy Radiother Oncol 89 2008 141 149
19. E.B. Hug, M. Nevinny-Stickel, and M. Fuss Conformal proton radiation treatment for retroperitoneal neuroblastoma: Introduction of a novel technique Med Pediatr Oncol 37 2001 36 41
20. A.L. Yu, A.L. Gilman, and M.F. Ozkaynak Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma N Engl J Med 363 2010 1324 1334